Alito Temporarily Restores FDA Rule Allowing Abortion Pill Mifepristone to Be Sent by Mail

Justice Samuel Alito of the United States Supreme Court has temporarily restored a Food and Drug Administration (FDA) rule permitting the abortion pill mifepristone to be prescribed online and dispensed through the mail.

Legal Context

In 2023, the FDA implemented a rule allowing mifepristone to be prescribed via telemedicine and delivered by mail. The state of Louisiana challenged this rule, leading to a ruling by the Fifth Circuit Court of Appeals that reinstated the requirement for in-person consultations to obtain the drug.

Supreme Court's Temporary Stay

On May 4, 2026, Justice Alito issued an administrative stay, pausing the Fifth Circuit's ruling and allowing the continued distribution of mifepristone through telehealth services and mail delivery. This stay is set to expire on May 11, 2026, providing the Court time to consider the case further.

Implications for Abortion Access

Mifepristone, used in combination with misoprostol, is a widely used method for medication abortions in the United States. The Supreme Court's temporary order maintains access to this method without the need for in-person visits, which is particularly significant in states with restrictive abortion laws.

For more detailed information, refer to the original article on CBS News: Alito Temporarily Restores FDA Rule Allowing Abortion Pill Mifepristone to Be Sent by Mail.